Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Int J Mol Sci ; 19(1)2018 Jan 15.
Artigo em Inglês | MEDLINE | ID: mdl-29342925

RESUMO

In recent years, there has been an increase in the production of several types of nanoparticles (Nps) for different purposes. Several studies have been performed to analyse the toxicity induced by some of these individual Nps, but data are scarce on the potential hazards or beneficial effects induced by a range of nanomaterials in the same environment. The purpose of the study described here was to evaluate the toxicological effects induced by in vitro exposure of human cells to ZnO Nps in combination with different concentrations of other metal oxide Nps (Al2O3, CeO2, TiO2 and Y2O3). The results indicate that the presence of these Nps has synergistic or antagonistic effects on the cell death induced by ZnO Nps, with a quite marked beneficial effect observed when high concentrations of Nps were tested. Moreover, analysis by Western blot of the main components of the intracellular activation routes (MAPKs and NFκB) again showed that the presence of other Nps can affect cell activation. In conclusion, the presence of several Nps in the same environment modifies the functional activity of one individual Np. Further studies are required in order to elucidate the effects induced by combinations of nanomaterials.


Assuntos
Sobrevivência Celular/efeitos dos fármacos , Nanopartículas Metálicas , Metais , Proteínas Quinases Ativadas por Mitógeno/metabolismo , NF-kappa B/metabolismo , Óxidos , Óxido de Alumínio/química , Óxido de Alumínio/farmacologia , Sinergismo Farmacológico , Ativação Enzimática/efeitos dos fármacos , Humanos , Nanopartículas Metálicas/química , Metais/química , Metais/farmacologia , Óxidos/química , Óxidos/farmacologia , Solubilidade , Óxido de Zinco/química , Óxido de Zinco/farmacologia
2.
Future Sci OA ; 2(2): FSO118, 2016 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-28031965

RESUMO

Nanoparticles (Nps) can induce toxicity in the lung by accidental or intentional exposure. The main objective of the study reported here was to characterize the effect that four metal oxide Nps (CeO2, TiO2, Al2O3 and ZnO) had at the cellular level on a human lung epithelial cell line. This goal was achieved by studying the capacity of the Nps to activate the main mitogen-activated protein kinases (MAPKs) and the nuclear factor NFκB. Only ZnO Nps were able to activate all of the MAPKs and the release of Zn2+ ions was the main cause of activation. ZnO and Al2O3 Nps activated the NFκB pathway and induced the release of inflammatory cytokines. CeO2 and TiO2 Nps were found to have safer profiles. The graphical abstract was obtained using Servier Medical Art.

3.
Int J Nanomedicine ; 11: 4657-4668, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27695324

RESUMO

Besides cell death, nanoparticles (Nps) can induce other cellular responses such as inflammation. The potential immune response mediated by the exposure of human lymphoid cells to metal oxide Nps (moNps) was characterized using four different moNps (CeO2, TiO2, Al2O3, and ZnO) to study the three most relevant mitogen-activated protein kinase subfamilies and the nuclear factor kappa-light-chain-enhancer of the activated B-cell inhibitor, IκBα, as well as the expression of several genes by immune cells incubated with these Nps. The moNps activated different signaling pathways and altered the gene expression in human lymphocyte cells. The ZnO Nps were the most active and the release of Zn2+ ions was the main mechanism of toxicity. CeO2 Nps induced the smallest changes in gene expression and in the IκBα protein. The effects of the particles were strongly dependent on the type and concentration of the Nps and on the cell activation status prior to Np exposure.


Assuntos
Linfócitos/citologia , Linfócitos/efeitos dos fármacos , Metais/química , Nanopartículas/toxicidade , Óxidos/química , Óxidos/toxicidade , Regulação da Expressão Gênica/efeitos dos fármacos , Humanos , Células Jurkat , Linfócitos/metabolismo , Inibidor de NF-kappaB alfa/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA